购物车
全部删除
您的购物车当前为空
别名 CCR1 拮抗剂-9
CCR1 antagonist 9 (compound 19e)是一种基于氮唑啉的选择性CCR1拮抗剂,在钙通量(Ca2+ flux)实验中抑制CCR1的IC50=6.8 nM,对hERG的IC50=30 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
CCR1 antagonist 9 (compound 19e)是一种基于氮唑啉的选择性CCR1拮抗剂,在钙通量(Ca2+ flux)实验中抑制CCR1的IC50=6.8 nM,对hERG的IC50=30 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,120 | 现货 | |
| 5 mg | ¥ 2,480 | 现货 | |
| 10 mg | ¥ 4,130 | 现货 | |
| 25 mg | ¥ 6,490 | 现货 | |
| 50 mg | ¥ 8,750 | 现货 | |
| 100 mg | ¥ 11,800 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,730 | 现货 |
CCR1 antagonist 9 相关产品
| 产品描述 | CCR1 antagonist 9 (compound 19e) is a selective CCR1 antagonist based on aziridine. It exhibits an IC50 of 6.8 nM for CCR1 inhibition in calcium flux assays and an IC50 of 30 μM for hERG. |
| 靶点活性 | CCR1:6.8 nM |
| 体外活性 | CCR1 antagonist 9 可阻断THP-1细胞的CCR1趋化作用(IC50:28 nM),同时也能阻断hERG通道(IC50:30 μM)[1]。 |
| 别名 | CCR1 拮抗剂-9 |
| 分子量 | 425.44 |
| 分子式 | C20H16FN5O3S |
| CAS No. | 1220026-26-5 |
| Smiles | O=C(NCC=1C=CN=C(C1)S(=O)(=O)C)C2=CN=CC3=C2C=NN3C4=CC=C(F)C=C4 |
| 密度 | 1.46 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 64 mg/mL (150.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (5.88 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容